Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

7.500 +0.780 (+11.61%)
Official Closing Price Updated: 6:30 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
39 40 Next >
Allied, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55 
Via Benzinga
Research Suggests How Individuals Can Control Unwanted Thoughts
Via Investor Brand Network
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Scheduled Annual Shareholder Meeting
Via Investor Brand Network
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 2.76% at $14.91 LOSERS: 
Via Benzinga
Cybin Announces Date of Annual Meeting of Shareholders
From Cybin Inc.
Via Business Wire
Is It Safe to Smoke DMT?
Via Investor Brand Network
What You Should Know, Do Before Investing in Psychedelics Stocks
Via Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From July 22, 2022
GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50 
Via Benzinga
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: LOSERS: Allied (OTC:ALID) shares closed down 10.00% at $0.45 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 20, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 10.53% at $15.11 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Unlocking ‘New Frontiers of Discovery’ with Kernel Flow
Via Investor Brand Network
House Approves Amendments on Psychedelic Therapy in Defense Spending Measure
Via Investor Brand Network
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 8.09% at $0.93 
Via Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 7.69% at $13.02 
Via Benzinga
The 8 Largest Psychedelic Compounds-Based Drug Stocks: A Financial Assessment
A look at the stock performances of the 8 largest clinical-stage companies involved in the research and development of psychedelic compound-based drugs. 
Via Talk Markets
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 7.05% at $0.52 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 14, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.63% at $0.49 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 13, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.61 
Via Benzinga
Online Companies Offering Mental Health Services Come Under Spotlight
Via Investor Brand Network
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 4.15% at $0.66 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment
Via Investor Brand Network
Psychedelic Drug Stocks Index Up Last Week, Still Down YTD
The psychedelic Compounds-Based Drug Stocks Index was +24.0% last week; +33.5% in the last 5 weeks; but still -44.0% YTD. 
Via Talk Markets
Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
From Clinilabs Drug Development Corporation
Via Business Wire
Psychedelic Stock Gainers And Losers From July 11, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.67% at $0.54 
Via Benzinga
Congressional Leaders Want Studies to be Conducted on Mental Health Benefits of Psychedelics
Via Investor Brand Network
Topics Law Enforcement
Exposures Legal
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004
Via Investor Brand Network
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical
From Cybin Inc.
Via Business Wire
Allied, GH Research Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.74% at $12.85 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 7, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.62% at $0.54 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.